WASHINGTON, DC–(Marketwire – October 14, 2010) –  Despite the promise of a new era of health care in which medicine has shifted from treating conditions to emphasizing prevention fueled by individualized care, a significant gap remains in realizing its benefits because of outmoded attitudes, protocols and procedures targeted for treating mass populations. Such is the core argument and motivation behind the “Personalized Health Manifesto,” released today to kick off the 2010 Translational Medicine Alliance Forum (TMAF) at the Mandarin Oriental. 

Written by journalist and best-selling author David Ewing Duncan and funded by the Ewing Marion Kauffman Foundation, the manifesto is “an old-fashioned call to arms and action plan for a new age of health care” that takes direct aim at the challenges of integrating and implementing personalized health care in the United States and seeks to accelerate the incorporation of personalized health into the current health care system.

“Making this shift to personalized health is a formidable task that will take many years to accomplish, but having scientists and health care leaders sign on to a comprehensive plan is a powerful place to start,” Duncan said. “Launching a new era of personalized health will not require the creation of a radical new blueprint for change. We can use existing plans and reforms that individuals inside and outside of government have already proposed.”

“The manifesto is a fitting catalyst for conversation about how we can better and more quickly get cures to patients amid the billions being spent on research and drug development,” said Lesa Mitchell, vice president of advancing innovation at the Kauffman Foundation. “It directs us to focus on what we need to treat a patient, what we need to change in policy, what do we need to change in process, and how we need to more broadly share data to get the patient what he or she needs.” 

The manifesto’s “action plan” aims to set a new direction for health care, emphasizing prediction, prevention, individualized care and healthy wellness to ensure that the best medicines make it to the marketplace and optimize patient care. By focusing on the whole human organism, the manifesto challenges the prevailing use of drugs and protocols to target populations and averages rather than individuals. It further outlines the necessary groundwork for speeding up the process of moving from research to new drugs and other products and treatments by introducing more effective models that will ultimately improve health and reduce health care costs.

The manifesto was prepared with input from life science leaders representing medicine, business, government, patients, law and the media. Although the work is solely that of the author, these advisors have endorsed the manifesto, and many of them are convening at the TMAF today. The manifesto organizers hope to acquire the endorsement of at least 500 life science leaders by the end of the year. Anyone who reads the manifesto can add their name to the list of endorsers and leave comments by visiting www.kauffman.org/healthmanifesto.

The full manifesto is available at www.kauffman.org/manifesto.

The Ewing Marion Kauffman Foundation is a private nonpartisan foundation that works to harness the power of entrepreneurship and innovation to grow economies and improve human welfare. Through its research and other initiatives, the Kauffman Foundation aims to open young people’s eyes to the possibility of entrepreneurship, promote entrepreneurship education, raise awareness of entrepreneurship-friendly policies, and find alternative pathways for the commercialization of new knowledge and technologies. It also works to prepare students to be innovators, entrepreneurs and skilled workers in the 21st century economy through initiatives designed to improve learning in math, engineering, science and technology. Founded by late entrepreneur and philanthropist Ewing Marion Kauffman, the Foundation is based in Kansas City, Mo. and has approximately $2 billion in assets. For more information, visit www.kauffman.org, and follow the Foundation on www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.

David Ewing Duncan is an award-winning, best-selling author of seven books published in 19 languages; he is a journalist and a television, radio and film producer and correspondent. His most recent book is the bestseller Experimental Man: What one man’s body reveals about his future, your health, and our toxic world. He is Chief Correspondent of public radio’s Biotech Nation and a columnist for Fortune. He is the Director of the Center of Life Science Policy at UC Berkeley. He has been a commentator on NPR’s Morning Edition, and a contributing editor for Wired, Discover and Conde Nast Portfolio. David writes for The New York Times, National Geographic, Harper’s, Atlantic Monthly, the San Francisco Chronicle, and many other publications. He is a former special correspondent and producer for ABC Nightline and a correspondent for NOVA’s ScienceNOW! He has won numerous awards including the Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing. He is a graduate of Vassar College and now lives in San Francisco.

The Translational Medicine Alliance Forum, hosted by the Kauffman Foundation, the Council for American Medical Innovation and FasterCures, convenes with the common interest of accelerating translational research to the patient. The Forum brings together leaders from academia, government agencies, and pharmaceutical, biotechnology, and venture industries to work toward developing a deeper understanding of effective models to enable and accelerate the progress of translational medicine. Through focused, dynamic sessions and exclusive networking opportunities, attendees have the opportunity to learn about breakthrough approaches and progress on current best practices in translational medicine collaborations. This Forum will focus on the following topics: regulatory science, lessons from the most experienced translational models, how and why rare disease and pediatric medicine are changing the landscape, transparency and access to data, and reverse engineering translational science starting with the patient.

Click here to see all recent news from this company

MADISON, WI–(Marketwire – October 14, 2010) –  TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that it will release its 2010 third quarter results on Thursday, October 28, 2010 at 3:00 p.m. CDT.

TomoTherapy will hold an investment community conference call on Thursday, October 28, 2010 beginning at 4:00 p.m. CDT. Fred Robertson, M.D., CEO, and Thomas Powell, CFO, will review third quarter performance and discuss the company’s strategies. To join the conference call, dial 1-800-638-4817 (international 1-617-614-3943) and enter passcode 19539609. A replay of the conference call will be available one hour after the call ends through 10:59 p.m. CDT on November 4, 2010. To access the replay, dial 1-888-286-8010 (international 1-617-801-6888) and enter passcode 40905886.

For individual investors, a live Webcast of the conference call will be available on the Investor Relations page of TomoTherapy.com. Institutional investors can access the Webcast through a password-protected site www.streetevents.com. An archived Webcast of TomoTherapy’s conference call will be available for two weeks.

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy^® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art^® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD^™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

SAN FRANCISCO, CA–(Marketwire – October 14, 2010) –  Mindjet®, the leading provider of software and web-based applications for visually organizing and managing information and ideas, today announced the successful implementation of MindManager™ version 9 with MedMan, a leading medical management services company based in Boise, Idaho. MedMan was looking for a solution to help get closer alignment on internal operations and access to customer information for its 25 remote working employees so they could drive more strategic business plans for their dispersed medical practice client base. MedMan deployed MindManager to help employees create and organize all vital business documents, such as client rosters, HR documents and new hire information, in MindManager so information is easy to access, update and share. Using MindManager, MedMan is able to better serve its clients by providing in-depth and interactive strategy plans that foster idea generation and increase productivity.

MedMan provides administrative and business assistance and consultation for clinics, physician-owned and private medical practices. With numerous clients across multiple states and a workforce that is spread across the country, the business was difficult to keep on track. MedMan needed an easy-to-use and understand platform for tracking key pieces of information related to its clients and business.

“The methodology behind MedMan’s business is helping our clients prioritize needs and establish operational efficiencies to more effectively manage their medical practices,” said Jim Trounson, President of MedMan. “The beauty of MindManager is that we can easily create an actionable business plan with goals, owners and deadlines and work in real-time with the client to show progress and quickly revise the plan when needed. This allows us to the make decisions quicker and faster, making business better for our clients and MedMan.”

MedMan has also taken advantage of the new features in MindManager version 9 including the enhanced integration with Microsoft Outlook, the resource availability feature and the Gantt Project View to understand when clients have available assets and how MedMan can effectively use those to better a client’s business.

“Resource and project management is something that is essential to the survival of any business, whether providing services to clients or providing healthcare to patients,” said Scott Raskin, CEO of Mindjet. “MedMan’s use of MindManager demonstrates the power of visualizing pieces of information that are critical to everyday business function and we are excited to help MedMan provide a unique and necessary service to medical professionals.”

By using MindManager’s extensive visual environment and its innate ability to organize and manage all forms of data and information, MedMan has created elaborate maps that contain all pieces of relevant information for any client, ranging from current business plans, to action items to client rosters. With MindManager, MedMan has been able to strengthen its relationship with existing clients, acquire new ones and provide all clients the service needed to keep business thriving.

MindManager’s visual information maps start with a central theme, and then add branches with ideas, notes, images, tasks, hyperlinks and attachments. Users can easily import from all types of information sources. MindManager maps are used to capture and organize information, and quickly transform thoughts and ideas into fine-tuned visual representations, documents, compelling presentations and winning strategies. MindManager provides a better way to brainstorm, organize facts, plan projects, and communicate results. Users have access to tight integration with Microsoft Outlook and Office to keep the constant stream of information for a project organized in one easy-to-access location, and a visualization and dashboard tool for SharePoint environments with MindManager Explorer for SharePoint. Collaboration tools, real-time map co-editing and web based document storage with Mindjet Catalyst is also available.

For more information visit: www.Mindjet.com

About MedMan
Founded by Jim Trounson in 1977, MedMan’s business model was based on Jim’s experience with outsourcing management companies that were improving the efficiency of hospitals by centralizing and computerizing many of their management functions. MedMan’s goal is to positively affect healthcare delivery to one million patients per year by 2015, based on a proven ability to provide an elite team of professional practice administrators to physician-driven medical clinics.

About Mindjet
Mindjet provides productivity software that helps business professionals visually organize and act upon ideas, information, and resources to drive productivity, team effectiveness, and business innovation. Mindjet products include industry-leading software and online services centered on information mapping, as well as applications that incorporate Mindjet’s innovative visualization technology to improve the usability of leading business applications, including Microsoft® SharePoint® and Salesforce.com. More than 1.5 million people around the world use Mindjet software to clarify thinking, efficiently analyze information, increase team productivity, and make better-informed decisions.

Used by business professionals in 44 of BusinessWeek‘s® 50 “World’s Most Innovative Companies,” Mindjet solutions dramatically boost productivity and team effectiveness. Surveys across several industries show that Mindjet can increase productivity by up to 25 percent by making meetings, common communications, and project management tasks more efficient and effective. Mindjet products are available for free trial or purchase at www.mindjet.com/products/overview, through salesforce.com AppExchange, and through an extensive partner network at www.mindjet.com/community/partners/overview. Mindjet is headquartered in San Francisco and has offices throughout the U.S., Europe and Asia.

id=”nav_links”>

CHICAGO, IL–(Marketwire – October 13, 2010) –  Ziegler (PINKSHEETS: ZGCO) kicked off its 13^th annual Ziegler Senior Living Finance + Strategy Conference at The Hyatt Regency Resort & Spa in Bonita Springs, Florida on Wednesday, September 29, 2010.

The three-day, invitation-only educational conference attracted over 500 attendees and presented cutting-edge finance and strategic positioning trends and issues in senior living and the senior living capital markets. Tom Paprocki, President and CEO of The Ziegler Companies, welcomed the senior living providers, institutional investors, and other industry professionals and introduced the conference facilitator, Dan Hermann, Senior Managing Director & Head of Ziegler Senior Living Finance.

The Ziegler banking team conducted pre-conference workshops allowing attendees to enhance their knowledge of the senior living sector. Such workshops included “Senior Living Finance 101,” “Financial Risk Management 101,” a legal roundtable and a senior living-focused board development workshop. The Ziegler CFO Workshop Series(SM) provided CFOs a roundtable and networking session. All workshops were well attended and provided a general overview of the vast capabilities Ziegler offers.

The opening general session led by a team of capital markets experts laid the foundation for the conference curriculum. The session was a tightly narrated review of the trends unfolding across the senior living continuum and current capital markets investors’ and lenders’ landscapes. Mr. Hermann and Kathryn Brod, Ziegler’s Senior Vice President-Research, and Mike McDaniel, Ziegler’s Senior Managing Director of Sales & Trading, reviewed key trends; Ron Mintz (Vanguard) and Jim LeBuhn (FitchRatings) provided perspectives from the investor and rating agency, respectively. Each educational session of the conference was introduced, tying each to the trends and setting the context for the conference curriculum that would follow.

An array of breakout sessions was offered to attendees. Some hot topics of the conference included case studies of creative solutions for overcoming housing market challenges; key marketing tools for invigorating occupancy; case studies of providers offering services beyond their boundaries; wellness initiatives; and the impact of healthcare reform on the sector. Sessions also included discussions in trends focusing on repositionings and new campus development. Institutional investor, banking, and architects’ panels were also featured. Educational sessions were offered in areas such as investment policymaking, mergers and acquisitions, and corporate structure. All sessions were lead by industry leaders, key associates from senior living providers and Ziegler team experts.

The conference concluded with a panel discussing senior living today, tomorrow and scenarios of the future. For further information on Ziegler or the conference, please visit our website at www.zieglerseniorlivingfinance.com.

About Ziegler:
The Ziegler Companies, Inc. (PINKSHEETS: ZGCO) together with its affiliates (Ziegler) is a specialty investment bank with unique expertise in complex credit structures and advisory services. Nationally, Ziegler is ranked as one of the leading investment banking firms in its specialty sectors of healthcare, senior living, religion and education finance, as well as corporate finance and FHA/HUD. Headquartered in Chicago, IL with regional and branch offices throughout the U.S., Ziegler creates tailored financial solutions including bond financing, advisory, private placement, seed capital, M&A, risk and asset management. Ziegler serves institutional and individual investors through its wealth management and capital markets distribution channels.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

MELVILLE, NY–(Marketwire – October 13, 2010) – FONAR Corporation (NASDAQ: FONR), The Inventor
of MR Scanning™, today announced its financial results for the fiscal
year ending June 30, 2010. Total revenues were $31.8 million for the fiscal
year ended June 30, 2010 as compared to $39.7 million for fiscal 2009. The
net loss for the fiscal year ended June 30, 2010, was $3.0 million, as
compared to a net income of $1.1 million for fiscal 2009. The net loss per
share (basic and diluted) for the fiscal year ended June 30, 2010 was
$0.61, as compared to a net income per share (basic and diluted) of $0.21
for the fiscal year ended June 30, 2009.

Revenues from the management of the UPRIGHT® Multi-Position™ MRI
Centers was at $11.1 million for the year ended June 30, 2010 as compared
to $10.3 million one year earlier.

Revenues from UPRIGHT® MRI service and repair fees increased to $11.1
million for the fiscal year ended June 30, 2010 as compared to $10.5
million one year earlier.

Revenues from product sales of the FONAR UPRIGHT® Multi-Position™ MRI
scanners were $9.1 million in the fiscal year ended June 30, 2010, as
compared to $17.2 million in the fiscal year ended June 30, 2009. On June
30, 2010 there were 143 FONAR UPRIGHT® Multi-Position™ MRI scanners
installed in the United States and around the world.

“Total costs and expenses related to operations decreased 15%, from $40.4
million in the fiscal year ended June 30, 2009, to $34.4 million in the
fiscal year ended June 30, 2010,” said Raymond Damadian, M.D., Chairman and
President of Fonar Corporation. “The Company has taken strenuous steps to
controlling costs while continuing to run its business including producing
the FONAR UPRIGHT® Multi-Position™ MRI scanner. These cost cutting
programs were first begun over two years ago.”

At June 30, 2010, total assets were $21.6 million, total current assets
were $14.7 million, total current liabilities were $24.7 million, total
stockholders’ deficiency was $5.8 million and total long-term liabilities
were $2.7 million. Total cash and marketable securities were $1.3 million.
The backlog for MRI product was $14.9 million.

Dr. Damadian remarked, “FONAR has been faced with an ongoing recession and
uncertainty with regard to reimbursement and health care reform. Perhaps
most significant is the prevention of FONAR customers to obtain credit in
this difficult banking environment. Subsequently, FONAR has had to make a
massive amount of cost cuts. Reductions have been made in many categories
most significantly in research and development (R&D), and selling, general
and administrative (S, G & A) areas. Overall, R&D and S, G & A expenses
were reduced over 15% to $14.4 million for the fiscal year ending June 30,
2010 as compared to $17.0 million during the fiscal year ending at June 30,
2009.”

Dr. Damadian said, “FONAR’s prospects have much improved since our nation’s
financial difficulties last year and our customers’ uncertainties regarding
the Deficit Reduction Act (DRA) have eased. Over the past few years, the
medical evidence continues to grow indicating that the FONAR UPRIGHT®
Multi-Position™ MRI is the best MRI for diagnosing spinal problems such
as low back pain or motor vehicle whiplash injuries of the neck as well as
symptoms in other weight-bearing structures of the human body (e.g. knee,
hip, ankle, foot, shoulder, etc.). So as pent-up demand for MRI scanners
surfaces, we look forward to rising sales.”

Fiscal Year Highlights

Dr. Damadian said, “Many of the 2010 fiscal year highlights included
UPRIGHT® MRI installations, an important journal research paper and
significant increases in the patient scan totals among the 9 UPRIGHT®
Multi-Position™ (STAND-UP® MRI) imaging centers managed by FONAR’s
subsidiary Health Management Corporation of America (HMCA). In fact for
fiscal 2010, the scanning centers are now performing collectively
approximately 300 scans per month at each of the nine centers, a 16%
increase over that of the previous year.”

The July 2010 issue of the medical journal “Brain Injury”
(www.fonar.com/news/072110.htm) published a very significant study of 1200
neck pain patients comparing the FONAR UPRIGHT® Multi-Position™ MRI to
a conventional recumbent MRI and the ability to diagnose whiplash trauma
from a motor vehicle accident. The 1200 neck pain patients were divided
into 4 groups, consisting of 2 control neck pain groups that did not
experience whiplash trauma and 2 neck pain groups that did. The
radiologists who read the study images were blinded as to which images were
the patient images and which were the control images. The patients were
examined in both the upright and recumbent positions. The recumbent MRI
images were obtained in a conventional recumbent MRI and the upright images
were obtained in the FONAR UPRIGHT® MRI. The “Brain Injury” study showed
that the fallen cerebellar tonsils (CTE) caused by motor vehicle whiplash
injuries were being missed 60% of the time where the patient was scanned
recumbent-only in a conventional “lie-down MRI” and not scanned upright.
As a result of this study, the medical evidence indicated that the fallen
cerebellar tonsils of a whiplash injury patient can now be reliably
visualized by using the FONAR UPRIGHT® Multi-Position™ MRI. In fact a
customer who recently purchased the FONAR UPRIGHT® MRI said that ‘From
our point of view, here in Germany, the newly published 1200 patient study
in “Brain Injury” sets a “new standard of care” for whiplash injury
patients.’ (www.fonar.com/news/080310.htm)

During the fiscal year ended June 30, 2010, FONAR added to its world-wide
installed base of FONAR UPRIGHT® Multi-Position™ MRIs. Among them was
an installation at Hospital ZorgSaam Zeeuws-Vlaanderen, Terneuzen, The
Netherlands. This 340-bed hospital performs a significant amount of
orthopedic and spine surgery. In addition, it is one of the biggest
centers in The Netherlands for the treatment of bariatric patients. The
UPRIGHT® MRI was sold by Tecserena GmbH, FONAR’s European distributor
since 2006. At the time of the sale, radiologists at Hospital ZorgSaam
Zeeuws-Vlaanderen said they sought the advanced technology provided by the
FONAR UPRIGHT® Multi-Position™ MRI to increase the diagnostic
precision of the images of weight-bearing anatomy, establishing for their
hospital a new standard of excellence throughout Europe for orthopedic
surgical outcomes.

The year was also a big year for North Carolina installations. Prior to
this year there were no FONAR UPRIGHT® Multi-Position™ MRIs in the
state. This year UPRIGHT® MRIs were installed in Charlotte and Durham.
Introducing the FONAR UPRIGHT® Multi-Position™ MRI in North Carolina
was a lengthy process as that state has certificate of need laws designed
to limit the number of advanced medical equipment units entering the state.

Pocatella, Idaho, Las Vegas, Nevada, and Duluth, Minnesota were also
recipients of the UPRIGHT® MRI scanner. For Minnesota, this is the third
scanner purchased by the Center for Diagnostic Imaging (CDI), one of the
nation’s premier diagnostic center businesses. In addition, as the fiscal
year ended, installation of the first UPRIGHT® MRI scanner in Africa was
nearing completion.

Dr. Damadian said, “We are delighted with the results of our efforts on
‘selling scans’ at the nine UPRIGHT® Multi-Position™ MRI, aka
STAND-UP® MRI, managed sites. Currently, the Company manages nine
STAND-UP® MRIs and an earlier model FONAR QUAD™ MRI through its
wholly-owned subsidiary, HMCA (Health Management Corporation of America;
www.hmca.com). The centers’ performance improved steadily monthly. In fact,
the nine STAND-UP® MRIs performed a record 3,183 scans during the month
of March, 2010, an average of 354 per scanner. This is a 35% increase as
compared to 2,354 scans done during the month of March 2009, one year
earlier.”

“We are delighted with the response of referring physicians to the
STAND-UP® MRI. It is becoming increasingly obvious to referring
physicians that scanning patients without the force of gravity, which is
the case with all single-position, recumbent-only MRI scanners, results in
missed, critical pathology,” said Dr. Damadian. “These physicians are now
referring their patients to the scanner and experiencing more accurate
diagnoses and better outcomes for their patients as a result of scanning
them upright and fully weight-bearing in the exact position that generates
their symptoms, which the FONAR UPRIGHT® Multi-Position™ MRI makes
possible. Additionally, patients themselves appreciate the spacious,
non-claustrophobic process of being seated comfortably while watching
television throughout their scan. Mothers can enter the scanner with their
infant on their laps. The infant watching his favorite television cartoon
throughout the scan, remains motionless thereby avoiding the need for
anesthesia which currently is required for scanning the vast majority of
children under the age of seven when they are scanned in a conventional
lie-down MRI.”

Matters concerning holders of FONAR Corporation stock certificates

Recently, many of our shareholders have received letters from CST (Computer
Share Trust), www.computershare.com, telephone 800-962-4284. It is very
important for investors to respond to these letters or else risk of being
subject to state escheatment laws. Essentially, shareholders holding
older, pre-reverse stock-split certificates must exchange their old
certificates for new ones.

In addition, investors may have changed addresses or appeared to have
abandoned their stock. If this could possibly be you, we urge you to
contact CST to update your information.

Again please call CST at 800-962-4284. For more information on FONAR stock
please visit: www.fonar.com/invest_faq.htm

For investor and other information visit: www.fonar.com.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR
Scanning™, Full Range of Motion™, pMRI™, Dynamic™,
Multi-Position™, True Flow™, The Proof is in the Picture™,
Spondylography™ Spondylometry™ and Upright Radiology™ are
trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that
may or may not materialize. Additional information on factors that could
potentially affect the company’s financial results may be found in the
company’s filings with the Securities and Exchange Commission.

                  FONAR CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEETS

                                ASSETS
                                ------


                                                         June 30,
                                                --------------------------
                                                    2010          2009
                                                ------------  ------------
Current Assets:
  Cash and cash equivalents                     $  1,299,493  $  1,225,619
  Marketable securities                               27,613        22,652
  Accounts receivable - net of allowances for
   Doubtful accounts of $2,289,049 and
   $2,393,326 at June 30, 2010 and 2009,
   respectively                                    4,820,541     5,391,822
  Medical receivables - net of allowances for
   Doubtful accounts of $1,622,000 and
   $1,343,500 at June 30, 2010 and 2009,
   respectively                                       25,225       374,225
  Management fee receivable - net of allowances
   for Doubtful accounts of $5,808,345 and
   $5,093,345 at June 30, 2010 and 2009,
   respectively                                    2,568,526     3,273,756
  Management fee receivable - related medical
   Practices - net of allowances for doubtful
   Accounts of $1,129,818 and $1,094,818 at
   June 30, 2010 and 2009, respectively            1,921,983     2,196,580
  Costs and estimated earnings in excess of          
   billings on uncompleted contracts                 277,384     1,475,706
  Inventories                                      2,826,211     3,172,397
  Current portion of advances and notes to
   related medical practices                          83,423       164,611
  Current portion of note receivable - net of
   allowances for doubtful accounts of $115,000
   and $65,000 at June 30, 2010 and at
   June 30, 2009, respectively                       271,796       517,934
  Prepaid expenses and other current assets          552,800       472,397
                                                 -----------   -----------
      Total Current Assets                        14,674,995    18,287,699

Property and Equipment - Net                       2,108,556     2,892,380

Advances and Notes to Related Medical Practices -
 net of allowances for doubtful accounts of
 $264,791 at June 30, 2010 and at June 30, 2009        -            89,032

Notes Receivable                                       -         1,778,626

Other Intangible Assets - Net                      4,291,419     4,920,241

Other Assets                                         553,875       391,237
                                                ------------  ------------
      Total Assets                              $ 21,628,845  $ 28,359,215
                                                ============  ============


                  FONAR CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEETS

                              LIABILITIES
                              -----------


                                                         June 30,
                                                --------------------------
                                                    2010          2009
                                                ------------  ------------
Current Liabilities:
  Current portion of long-term debt and capital
   Leases                                       $    579,436  $    277,494
  Current portion of long-term debt - related
   party                                              87,835        79,509
  Accounts payable                                 3,191,960     3,518,609
  Other current liabilities                        8,065,069     8,460,042
  Unearned revenue on service contracts            5,219,547     5,526,006
  Customer advances                                4,813,327     9,237,921
  Billings in excess of costs and estimated
   earnings on uncompleted contracts               2,743,398     2,026,441

                                                ------------  ------------
      Total Current Liabilities                   24,700,572    29,126,022
                                                ------------  ------------
Long-Term Liabilities:
  Accounts payable                                    62,622       184,168
  Due to related medical practices                   527,891       643,135
  Long-term debt and capital leases, less
   current portion                                 1,566,622       759,211
  Long-term debt, less current portion -
   related party                                      72,341       160,176
  Other liabilities                                  474,763       427,365
                                                ------------  ------------
      Total Long-Term Liabilities                  2,704,239     2,174,055
                                                ------------  ------------
      Total Liabilities                           27,404,811    31,300,077
                                                ------------  ------------
Commitments, Contingencies and Other Matters


                  FONAR CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEETS

                       STOCKHOLDERS' DEFICIENCY
                       ------------------------


                                                         June 30,
                                                --------------------------
                                                    2010          2009
                                                ------------  ------------
Stockholders' Deficiency:
  Class A non-voting preferred stock - $.0001
   par value; authorized - 1,600,000 shares;
   issued and outstanding - 313,451 shares
   at June 30, 2010 and 2009                    $         31  $         31
  Preferred stock - $.001 par value;
   authorized - 2,000,000 shares; issued
   and outstanding - none                               -             -
  Common stock - $.0001 par value; authorized -
   30,000,000 shares at June 30, 2010 and 2009,
   respectively; issued - 4,985,850 and
   4,917,918 shares at June 30, 2010 and 2009,
   respectively; outstanding - 4,974,207 and
   4,906,275 shares at June 30, 2010 and 2009,
   respectively                                          497           491
  Class B common stock (10 votes per share) -
   $.0001 par value; authorized - 800,000
   shares; issued and outstanding - 158 shares
   at June 30, 2010 and 2009                            -             -
  Class C common stock (25 votes per share) -
   $.0001 par value; authorized - 2,000,000
   shares; issued and outstanding - 382,513
   shares at June 30, 2010 and 2009                       38            38
  Paid-in capital in excess of par value         172,379,863   172,280,600
  Accumulated other comprehensive loss               (18,489)      (20,995)
  Accumulated deficit                           (177,271,349) (174,258,607)
  Notes receivable from employee stockholders       (191,167)     (267,030)
  Treasury stock, at cost - 11,643 shares
   of common stock at June 30, 2010 and 2009        (675,390)     (675,390)
                                                ------------  ------------
      Total Stockholders' Deficiency              (5,775,966)   (2,940,862)
                                                ------------  ------------
      Total Liabilities and Stockholders'
        Deficiency                              $ 21,628,845  $ 28,359,215
                                                ============  ============


                  FONAR CORPORATION AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF OPERATIONS

                                               For the Years Ended June 30,
                                               ---------------------------
                                                   2010           2009
                                               ------------   ------------
Revenues
  Product sales - net                          $  9,056,307   $ 17,175,417
  Service and repair fees - net                  10,864,927     10,345,091
  Service and repair fees - related parties -
   net                                              220,000        192,500
  Management and other fees                       7,302,216      7,342,614
  Management and other fees - related
   medical practices - net                        3,786,612      2,911,318
  License fees and royalties                        585,493      1,755,493
                                               ------------   ------------
      Total Revenues - Net                       31,815,555     39,722,433
                                               ------------   ------------
Costs and Expenses
  Costs related to product sales                  7,248,756     10,758,201
  Costs related to service and repair fees        3,026,598      3,992,557
  Costs related to service and repair fees
   - related parties                                 61,284         74,293
  Costs related to management and other fees      5,320,756      4,507,587
  Costs related to management and other fees
   - related medical practices                    2,962,826      2,790,745
  Research and development                        2,458,342      3,593,470
  Selling, general and administrative,
   inclusive of compensatory element of stock
   issuances of $99,269 and $4,061 for the
   years ended June 30, 2010 and 2009,
   respectively                                  11,939,223     13,423,066
  Provision for bad debts                         1,378,500      1,286,451
                                               ------------   ------------
      Total Costs and Expenses                   34,396,285     40,426,370
                                               ------------   ------------
      Loss from Operations                       (2,580,730)      (703,937)

Other Income and (Expenses):
  Interest expense                                 (313,416)      (333,229)
  Interest expense - related parties                (74,486)         -
  Investment income                                 249,290        325,688
  Interest income - related parties                  10,926         20,818
  Other income - net                                 45,674        399,662
  Loss on note receivable                          (350,000)         -
  Gain on sale of consolidated subsidiary             -          1,448,196
                                               ------------   ------------
      (Loss) Income Before Provision For
       Income Taxes                              (3,012,742)     1,157,198

Provision for Income Taxes                            -             35,931
                                               ------------   ------------
       Net (Loss) Income                       $ (3,012,742)  $  1,121,267
                                               ============   ============

SAN DIEGO, CA–(Marketwire – October 13, 2010) –  SpectraScience, Inc. (OTCBB: SCIE), a San Diego based medical device company, today announced that Jim Hitchin, the Company’s current Chairman and CEO, resigned as Chairman effective October 8, 2010 and that the Board elected Mark McWilliams to assume the duties of Chairman of the Board of Directors.

Jim Hitchin, SpectraScience’s CEO, said, “The Company is planning its future growth strategy and as a part of best practices and good governance is separating the Chairmanship from the Chief Executive Officer role consistent with Sarbanes-Oxley guidance.”

Mr. McWilliams has served as a Director of the Company since 2004 and brings his expertise in managing and growing technology companies, a strong network of contacts in the medical device industry and experience in technology transactions. Mr. McWilliams also serves as the CEO of Medipacs, Inc., a development stage infusion pump company. Prior to that, from December 2003 to November 2005, he was Director of Cell Imaging and Analysis at Beckman Coulter after the sale of Q3DM to Beckman in December 2003. He was President and Chief Executive Officer and Director of Q3DM, from October 2001 to December 2003, a life-sciences startup that raised several angel and venture capital funding rounds that was acquired by Beckman Coulter. Previously, he was founder and COO of Medication Delivery Devices (“MDD”), an alternate care infusion systems company that was acquired by Baxter Healthcare in 1996. Mr. McWilliams served as a VP of Research and Development at Baxter Healthcare for three years following the sale of MDD. Prior to MDD, he served as Product Development Manager at the founding of Block Medical where he was responsible for bringing the company’s first two FDA approved products rapidly to market. Block was sold to Hillenbrand Industries in 1991. He previously worked for Hughes Aircraft, Vacuum General and Martin Marietta. Mr. McWilliams has expertise in managing and growing small technology companies and has a strong network of contacts within the medical devices industry. He earned his MSME from the Massachusetts Institute of Technology, his BSME from Northeastern University and holds eight utility patents.

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience’s actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience’s other reports filed with the Securities and Exchange Commission (“SEC”) that attempt to advise interested parties of the risks and factors that may affect SpectraScience’s business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company’s LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.

HILO, HI–(Marketwire – October 13, 2010) –   Pacific Quest recently held an informational and educational gathering for visiting educational consultants on the Big Island of Hawaii. Educational consultants arrived from the Midwest, East and West Coast, and Southern U.S. to learn about Pacific Quest’s wilderness therapy programs for struggling youth and young adults. Guests were greeted in camp with a welcoming ceremony, drumming circle, and a nutritious lunch prepared by Pacific Quest students. Afterwards, a garden tour of the four organic farms captured the key components and stages of the program for the consultants.

The next morning, Pacific Quest therapists and wellness staff delivered interactive presentations about the wilderness therapy program. Following the educational presentations, the group spent an afternoon engaging on the gardens and with students in the various phases of the wilderness program. Staff and guests put on work gloves and joined students in working in the nursery, transplanting plants, and harvesting mangoes and papayas on the farm. Students shared their experiences and knowledge of the farm with the visitors and were active teachers for the day.

What came from this gathering was an exchange of knowledge between educational consultants and the students and staff at Pacific Quest. Guests were able to experience the students’ daily life and engage in learning about the mind-body-emotion connection. By hosting this event, Pacific Quest was able to share its sustainable growth model through experiential education, informational sessions, and one-on-one interaction with students and staff.

For more information regarding Pacific Quest, please visit www.pacificquest.org or contact Mark Agosto, Outreach Director, at (808) 937-5806 or via email at [email protected]. Read more at: http://www.pacificquest.org/news/3/196/Pacific-Quest-Wilderness-Therapy-Program-Celebrates-First-Annual-Educational-Consultant-Gathering/.

About Pacific Quest:

Pacific Quest is an outdoor behavioral healthcare (“wilderness therapy”) and sustainable treatment program for struggling teens and young adults, located on the Big Island of Hawaii. Their wilderness programs offer a clinical, yet holistic approach to treatment, going beyond traditional therapy and teaching sustainable life skills. Owned and operated by a veteran team of professionals with over 200 years of combined program experience, Pacific Quest offers a unique approach to treatment that is individualized for each student. Through experiential education, clinical services, a dedicated approach to health and wellness, and sustainable gardening, Pacific Quest provides a structured yet flexible outdoor therapy environment that serves the individual needs of each student.

Click here to see all recent news from this company

LEBANON, OR–(Marketwire – October 13, 2010) –  The College of Osteopathic Medicine of the Pacific-Northwest campus has yet to open its doors in Lebanon, Ore., but prospective students are lining up to apply for the 100 slots available in the inaugural class that begins in fall 2011.

More than 1,400 applications have been received, with several months left in the application process. The interview process began on Oct. 9 and applications will be accepted until Feb. 1, 2011.

“The early deluge of applications only codifies our historic belief that there was a significant unmet need both for medical education and health care services in geographic locations outside the major metropolitan areas of Seattle and Portland,” said COMP Dean Clinton Adams, DO.

Thirty-nine applicants, mostly from the northwest region, traveled to Lebanon for their formal interview with the school on Oct. 9. The interview is the final step in the application process to medical school following the primary and secondary written application documents.

The interviews were conducted by leaders who have volunteered to provide support for COMP-Northwest, including state and regional osteopathic physicians, Oregon business leaders, and representatives from Samaritan Health Services. The volunteers were divided into groups of three and conducted interviews for three to four applicants.

The interview day began with opening remarks by Dean Adams, followed by remarks from Paula Crone, DO, Executive Associate Dean for COMP-Northwest. The interviewees then received an orientation and overview of COMP, including presentations from Admissions, Financial Aid, Student Affairs and the COMP curriculum.

The day concluded with a 90-minute bus tour of the area, taking in the cities of Lebanon, Albany and Corvallis and highlighting the history, geography, amenities, activities and hospital facilities in each city.

“It’s very difficult for Oregonians and students from the Northwest to access medical education in the Northwest,” Adams said. “These students coming from the Northwest, educated in the Northwest, offer a significant solution to the health care needs of the Northwest as we face the ever-increasing demand for primary care and specialty services. The creation of a new opportunity for medical education in a small-town, rural environment will go a long way toward achieving our objective of providing health care to the many underserved areas of the Northwest.”

COMP-Northwest will be the first new medical school built in Oregon in more than a century.
The new COMP-Northwest facility is a 54,000-square-foot building due to be completed in spring 2011. The building contains two large lecture halls and four 60-seat classroom spaces, 15 student breakout and study rooms, an anatomy lab, an osteopathic manual medicine lab and significant research space.

COMP-Northwest is the approved new campus in the expansion of the College of Osteopathic Medicine of the Pacific, which was founded in Pomona, Calif. in 1977. COMP is now one of nine colleges that make up Western University of Health Sciences.

MENOMONEE FALLS, WI–(Marketwire – October 13, 2010) –  Assisted Living Concepts, Inc. (NYSE: ALC) announced that it plans to release its 2010 third quarter financial results before the New York Stock Exchange opens on Tuesday, November 2, 2010. The release will be posted on ALC’s website at www.alcco.com. ALC has scheduled a conference call on Tuesday, November 2, 2010 at 10:00 a.m. (EDT) to discuss its financial results for the third quarter. The toll-free number for the live call is (800) 230-1096 or international (612) 332-0335. A taped rebroadcast of the conference call will be available approximately three hours following the live call until midnight on December 2, 2010, by dialing toll free (800) 475-6701 or international (320) 365-3844 and using access code 174903.

About Us
Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences comprising 9,305 units in 20 states in the United States. ALC’s residences typically consist of 35 to 60 units and offer residents a supportive, home-like setting and assistance with activities of daily living. ALC employs approximately 4,100 people.

PLANTATION, FL–(Marketwire – October 13, 2010) – For the second year in a row, DentalPlans.com, the top online source for affordable and easy-to-use alternatives to dental insurance, is proud to donate a portion of the firm’s October proceeds to support breast cancer research and awareness. DentalPlans.com is pleased to reaffirm their commitment to women’s health and fund groundbreaking research, education, screening and treatment during National Breast Cancer Awareness Month. 

“As a leader in discount dental plans, our company is fully committed to the well being of our nation’s oral health,” said Buddy Johnson, CEO of DentalPlans.com, Inc. “We are proud to extend our support to raise public awareness and fund life-saving research to ultimately cure this devastating disease.”

In further support of the company’s campaign, DentalPlans.com has provided select network dentists and their staff members with pink dental scrubs and badges inscribed with a pink ribbon and the word ‘hope.’ “Any small thing we can do to eradicate this disease is a huge step forward,” said Dr. Peter Krimsky, who is proudly setting aside the conventional blue scrubs to wear pink ones along with his staff. “We’re raising awareness and prompting our patients to think.”

Dr. Krimsky’s office sees wearing pink as making a difference, one that will one day contribute to the end of the disease. Others are adopting the same thinking and pink is popping up where one might least expect. This year, the National Football League has teamed with the American Cancer Society to feature players, coaches and referees wearing pink apparel in the name of awareness. 

According to the American Cancer Society, breast cancer is the second leading cause of cancer death in women, after lung cancer. One out of eight American women who live to be 85 years of age will develop breast cancer, a risk that was one out of 14 in 1960. Excluding cancers of the skin, breast cancer is the most common cancer diagnosed among U.S. women, accounting for more than 1 in 4 cancers.

Interviews with DentalPlans.com representatives, members and network dentists are available. For more information about DentalPlans.com and editorial inquiries, please contact Shamin Abas or Elizabeth Rose of Shamin Abas Public Relations at 561.366.1226, [email protected] or [email protected]. 

About DentalPlans.com (www.DentalPlans.com)
DentalPlans.com is dedicated to improving oral health nationwide by making quality dental care affordable and accessible to everyone. DentalPlans.com proudly offers the freedom to choose from an extensive selection of discount dental plans designed to save members money on their dental care needs. With more than 40 years of experience in the dental industry, their devoted team quickly transformed DentalPlans.com into a trusted industry leader and the largest online provider of discount dental plans. Since 1999, DentalPlans.com has offered great value and convenience with an extensive choice of money-saving discount dental plans in one user-friendly website.

Click here to see all recent news from this company

TORONTO, ONTARIO–(Marketwire – Oct. 13, 2010) – Unison Health and Community Services is celebrating its official launch on Thursday, October 14^th, from 4 p.m. to 7 p.m., at its Lawrence Heights site located at 12 Flemington Road in Toronto. 

The entire community is invited to learn about Unison Health and Community Services and enjoy entertainment by local performers. There will also be children’s activities and contests, music and dancing, and refreshments.

In August, Unison Health and Community Services received its formal incorporation approval from Ministry of Government Services. This is the first voluntary merger of two community health centres in Ontario – the amalgamation of New Heights Community Health Centres and York Community Services.

Unison builds on the strengths and best practices of both organizations, aiming to improve access to programs and services for clients and community members. The optimal use of resources of both organizations will enhance the delivery of services in a more efficient and cost-effective manner. In collaboration with partners, the integrated services will provide seamless and comprehensive care to clients.

With extended hours at four full-service locations, clients now can have greater access to a wider variety of services. Unison now serves over 22,000 clients and offers core services that include primary health care, counselling, health promotion, early years programs, legal services, harm reduction programs, housing assistance and adult protective services; special programs like Pathways to Education, Diabetes Education and Prevention, and Aging at Home; and a range of community programs targeted to marginalized groups.

For event information, visit www.unisonhcs.org, or call 416-587-8225 or email [email protected].

BIRMINGHAM, UNITED KINGDOM–(Marketwire – Oct. 13, 2010) – A new study has revealed that the UK is a nation of over eaters and grazers with seven out of 10 people reaching for a snack on a regular basis.

The study, showed that half of Britons graze on food when they are bored whilst 23 per cent eat and snack more at times of crisis, turning to food to help them with their emotional needs.

Out of the 3000 people surveyed it was discovered that twice as many women as men snacked when they were stressed with only one in 10 reaching for a tasty treat when they were actually hungry.

Boredom was one of the key roles in overeating with 57 per cent of women scoffing down chocolaty treats and fatty delights and 40 per cent of men doing the same when they were fed up.

Other interesting reasons behind some of the UK’s snacking habits included eating at times of sadness as a way for people to cheer themselves up.

Those who are worried about being overweight should book a consultation with an expert bariatric surgeon at The Hospital Group.

The Hospital Group is the UK’s biggest provider of weight loss surgery, including gastric bands, gastric bypasses and gastric balloons.

David Ross, Chief Executive of The Hospital Group, said: “We are all guilty of having a snack every now and then especially when so many of us lead hectic lifestyles, a quick snack or readymade item can seem like the perfect choice to keep us going.

“However, it’s when people start to graze on a regular basis that it can be bad for their health. Eating sugary and fatty foods throughout the day can lead to weight gain and means that the body isn’t getting the vitamins or nutritional content that it needs.

“Those who are overweight often find themselves in a vicious circle, they want to lose weight and become more healthy but are locked in a battle with overeating and don’t know how to change their bad and harmful eating habits.

“Our consultants ensure that, as well as having an absolute need for a gastric procedure, the patient understands that weight loss surgery isn’t a miracle cure and they would need to work with the band to achieve the healthier lifestyle they desire.”

Since The Hospital Group was established in 1992, it has risen to become the UK’s biggest weight loss surgery providers, performing more gastric procedures last year than the NHS.

The Hospital Group is committed to providing the very highest standards and all procedures are performed by an expert medical team in state-of-the-art facilities that are second to none.

For further information of The Hospital Group’s range of weight-loss procedures, surgery-seekers should visit the website www.thehospitalgroup.org or call our patient care coordinators on 0845 762 6727.

SAN DIEGO, CA–(Marketwire – October 12, 2010) –  When San Diego resident Paul Henderson was hospitalized last year after a fall and subsequent hip surgery, he realized that even highly trained hospital staff were unable to meet his basic comfort needs — not because of lack of concern, but because as an Amyotrophic Lateral Sclerosis (ALS — more commonly known as Lou Gehrig’s disease) patient, he had lost the ability to speak. 

His week in the hospital ICU followed by two weeks at a rehab facility so impacted Henderson and his family — who had to be present at all times to interpret simple messages such as “I need my pain medication,” or “I need to go to the bathroom,” — that it inspired him to set up a new business designed to help anyone with limited speech ability in a care-giving situation.

Called “HelpMeSpeak, Inc.” (www.helpmespeakcards.com), the new company manufactures and sells reasonably priced message cards that can be used virtually anywhere — in hospitals, nursing facilities, rehab facilities or at home. The two-sided cards come in sets of 15, and have basic “needs” phrases in English and Spanish. They are ideally suited to individuals who have suffered strokes, paralysis, or who have other nerve/muscular-damaging diseases (such as ALS or muscular sclerosis). Henderson plans to donate $1 from every sale to the San Diego ALS Association. 

“I assumed that nursing staff would understand that ALS does not impact my mental capacity, only my ability to move and speak. I also assumed that they would be able to interpret my efforts to communicate, or to at least anticipate my basic needs,” said Henderson. “Unfortunately, I was wrong on all counts. They would talk to me as though as I was mentally impaired, and unfortunately, could not understand my efforts to communicate.

“As a result, I would lay cold in the bed for hours, or in pain, all because they couldn’t understand me.”

Henderson’s idea for HelpMeSpeak cards was so simple, he was sure a product like this must already exist. However, after contacting several hospitals and facilities, none were in use. Any communication products he found were not directed to basic patient care and cumbersome to use. 

The HelpMeSpeak cards are held by a ring that can be attached by a clip to a hospital gown or by a lanyard to a bedrail (or for patients not at risk of tangling, around the neck). The cards are color coded — red for English and black for Spanish. The cards are large enough that even if someone has limited hand mobility, it’s possible to handle them with relative ease. For patients without mobility, the caregiver can show the cards — thumbing through until the patient nods that his or her message has been selected.

HelpMeSpeak messages include: “I need my medications,” “Turn off the light,” “I am hot,” “I am cold,” “I am thirsty,” “I need to go to the toilet,” “I am hungry,” “I am OK,” etc. 

HelpMeSpeak cards can be ordered through the company website, www.helpmespeakcards.com, with individual set prices starting at $25 and per-unit Henderson plans to have a customization option introduced soon that will allow users/orders to expand the sets, or change the sets, with other messages as well.

About HelpMeSpeak
HelpMeSpeak, Inc., a San Diego-based company, is the creator and distributor of HelpMeSpeak cards, which are care cards designed by Paul Henderson, an ALS patient, to assist speech-impaired patients with communicating urgent needs to doctors, nurses and other caregivers. Each set of HelpMeSpeak cards contains 15 cards with messages translated in both English and Spanish. For more information, visit www.helpmespeakcards.com.

MENOMONEE FALLS, WI–(Marketwire – October 12, 2010) –  Assisted Living Concepts, Inc. (“ALC”) (NYSE: ALC) announced today that it entered into an agreement to acquire nine senior living residences from HCP, Inc. (NYSE: HCP). The nine residences are currently leased and operated by ALC under leases expiring between 2010 and 2012. The transaction, which is subject to customary closing conditions, is expected to close on or around October 31, 2010. The purchase price is $27.5 million plus certain transaction costs. The nine residences, two of which are located in New Jersey and seven in Texas, contain a total of 365 units. Occupancy of the nine residences is currently 60.0%. Upon completion of this transaction we expect pre-tax cash flow to improve by approximately $1.0 million because of the differential between current lease payments and expected future interest expense. After accounting for taxes we expect cash flow per share to improve by approximately $0.05 per share.

“We are pleased to have reached agreement with HCP to purchase these properties,” commented Laurie Bebo, President and Chief Executive Officer of Assisted Living Concepts, Inc. “In addition to upside opportunities in the existing portfolio, the better performing properties have excess land that may provide good expansion opportunities in the future. After this transaction is completed we will own 161 of our properties or 76% of our total residences.”

Non-GAAP Financial Measures
Cash Flow per Share

Cash flow is defined as cash provided by operating activities. Cash flow per share is defined as cash flow divided by the weighted average diluted common shares outstanding for a fiscal period. Cash flow per share is not a measure of performance under accounting principles generally accepted in the United States of America, or GAAP. We use cash flow per share as a performance indicator.

We understand that cash flow per share may be used by financial analysts and investors as a performance measure in evaluating a company’s ability to service debt and meet other payment obligations or as a common valuation measurement in the long-term care industry. We believe cash flow per share provides meaningful supplemental information because this measure excludes the effects of non-operating factors related to our capital assets, such as depreciation and amortization related to the assets.

About Us
Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences comprising 9,305 units in 20 states. ALC’s senior living facilities typically consist of 40 to 60 units and offer residents a supportive, home-like setting and assistance with the activities of daily living. ALC employs approximately 4,100 people.

Forward-looking Statements

Statements contained in this release other than statements of historical fact, including statements regarding anticipated financial performance, business strategy and management’s plans and objectives for future operations, including management’s expectations about improving occupancy and private pay mix, are forward-looking statements. Forward-looking statements generally include words such as “expect,” “project,” “point toward,” “intend,” “will,” “indicate,” “anticipate,” “believe,” “estimate,” “plan,” “strategy” or “objective.” Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. In addition to the risks and uncertainties referred to in the release, other risks and uncertainties are contained in ALC’s filings with United States Securities and Exchange Commission and include, but are not limited to, the following: changes in the health care industry in general and the senior housing industry in particular because of governmental and economic influences; changes in general economic conditions, including changes in housing markets, unemployment rates and the availability of credit at reasonable rates; changes in regulations governing the industry and ALC’s compliance with such regulations; changes in government funding levels for health care services; resident care litigation, including exposure for punitive damage claims and increased insurance costs, and other claims asserted against ALC; ALC’s ability to maintain and increase census levels; ALC’s ability to attract and retain qualified personnel; the availability and terms of capital to fund acquisitions and ALC’s capital expenditures; changes in competition; and demographic changes. Given these risks and uncertainties, readers are cautioned not to place undue reliance on ALC’s forward-looking statements. All forward-looking statements contained in this report are necessarily estimates reflecting the best judgment of the party making such statements based upon current information. ALC assumes no obligation to update any forward-looking statement.

Supplementary Financial Information  The following table is limited to financial information for the nine leased residents described above (in thousands, except per share number)

 

BENSALEM, PA–(Marketwire – October 12, 2010) – Healthcare Services Group, Inc. (NASDAQ: HCSG)
reported that revenues for the three months ended September 30, 2010
increased over 9% to $195,114,000 compared to $178,829,000 for the same
2009 period. Net income for the three months ended September 30, 2010
increased approximately 12% to $9,169,000 or $.21 per basic and per diluted
common share, compared to the 2009 third quarter net income of $8,225,000
or $.19 per basic and per diluted common share.

Revenues for the nine months ended September 30, 2010 increased over 12% to
$571,868,000 compared to $510,134,000 for the same 2009 period. Net income
for the nine months ended September 30, 2010 increased approximately 7% to
$25,318,000 or $.58 per basic and $.57 per diluted common share compared to
the 2009 nine month period net income of $23,776,000 or $.55 per basic and
$.54 per diluted common share.

The Board of Directors has declared a third quarter 2010 regular quarterly
cash dividend of $.2325 per common share, payable on November 5, 2010 to
shareholders of record at the close of business October 22, 2010. This
represents an increase over the dividend declared for the 2010 second
quarter, as well as an increase of 16% over the 2009 same period payment.
It is the 30th consecutive regular quarterly cash dividend payment, as well
as the 29th consecutive increase since our initiation of regular quarterly
cash dividend payments in 2003.

Additionally, our Board of Directors has declared a three-for-two stock
split in the form of a 50% stock dividend payable on November 12, 2010 to
holders of record of its Common Stock at the close of business November 8,
2010. All fractional share interests will be rounded up to the nearest
whole number. The effect of this action will be to increase Common Shares
outstanding by approximately 22,000,000 shares.

The Company will host a conference call on October 13, 2010 at 8:30 AM
Eastern Time to discuss its results for the three and nine month periods
ended September 30, 2010. The call in numbers are 888-259-8552 and
913-312-1406 (passcode # 8945410).

Cautionary Statement Regarding Forward-Looking Statements

This release and any schedules incorporated by reference into this report
may contain forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934 (the “Exchange Act”), as amended, which are not
historical facts but rather are based on current expectations, estimates
and projections about our business and industry, our beliefs and
assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,”
“will,” “goal,” and similar expressions are intended to identify
forward-looking statements. The inclusion of forward-looking statements
should not be regarded as a representation by us that any of our plans will
be achieved. We undertake no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise. Such forward-looking information is also subject to
various risks and uncertainties. Such risks and uncertainties include, but
are not limited to, risks arising from our providing services exclusively
to the health care industry, primarily providers of long-term care; credit
and collection risks associated with this industry; one client accounting
for approximately 11% of revenues in the nine month period ended September
30, 2010; risks associated with our acquisition of Contract Environmental
Services, Inc., including integration risks or costs, or such business not
achieving expected financial results or synergies or failure to otherwise
perform as expected; our claims experience related to workers’ compensation
and general liability insurance; the effects of changes in, or
interpretations of laws and regulations governing the industry, our
workforce and services provided, including state and local regulations
pertaining to the taxability of our services; and the risk factors
described in our Form 10-K filed with the Securities and Exchange
Commission for the year ended December 31, 2009 in Part I thereof under
“Government Regulation of Clients,” “Competition” and “Service
Agreements/Collections,” and under Item IA “Risk Factors.” Many of our
clients’ revenues are highly contingent on Medicare and Medicaid
reimbursement funding rates, which Congress has affected through the
enactment of a number of major laws during the past decade, most recently
the March 2010 enactment of the Patient Protection and Affordable Care Act
and the Health Care and Education Reconciliation Act of 2010. Currently,
the U.S. Congress is considering further changes or revising legislation
relating to health care in the United States which, among other
initiatives, may impose cost containment measures impacting our clients.
These laws and proposed laws and forthcoming regulations have significantly
altered, or threaten to alter, overall government reimbursement funding
rates and mechanisms. The overall effect of these laws and trends in the
long-term care industry have affected and could adversely affect the
liquidity of our clients, resulting in their inability to make payments to
us on agreed upon payment terms. These factors, in addition to delays in
payments from clients, have resulted in, and could continue to result in,
significant additional bad debts in the near future. Additionally, our
operating results would be adversely affected if unexpected increases in
the costs of labor and labor related costs, materials, supplies and
equipment used in performing services could not be passed on to our
clients.

In addition, we believe that to improve our financial performance we must
continue to obtain service agreements with new clients, provide new
services to existing clients, achieve modest price increases on current
service agreements with existing clients and maintain internal cost
reduction strategies at our various operational levels. Furthermore, we
believe that our ability to sustain the internal development of managerial
personnel is an important factor impacting future operating results and
successfully executing projected growth strategies.

Healthcare Services Group, Inc. is the largest national provider of
professional housekeeping, laundry and dietary services to long-term care
and related facilities.

                      HEALTHCARE SERVICES GROUP, INC.
                          CONDENSED CONSOLIDATED
                           STATEMENTS OF INCOME
                                (Unaudited)


                                                For the Three Months Ended
                                                        September 30,
                                                    2010          2009
                                                ------------- -------------
Revenues                                        $ 195,114,000 $ 178,829,000
Operating costs and expenses:
   Cost of services provided                      168,384,000   155,228,000
   Selling, general and administrative             14,488,000    11,936,000
                                                ------------- -------------
Income from operations                             12,242,000    11,665,000
Other income:
    Investment and interest income                  1,182,000     1,709,000
                                                ------------- -------------
Income before income taxes                         13,424,000    13,374,000
Income taxes                                        4,255,000     5,149,000
                                                ------------- -------------
Net income                                      $   9,169,000 $   8,225,000
                                                ============= =============

Basic earnings per common share                 $         .21 $         .19
                                                ============= =============

Diluted earnings per common share               $         .21 $         .19
                                                ============= =============

Cash dividends per common share                 $         .23 $         .19
                                                ============= =============
Basic weighted average number of
 common shares outstanding                         44,026,000    43,626,000
                                                ============= =============

Diluted weighted average number of
 common shares outstanding                         44,719,000    44,334,000
                                                ============= =============




                      HEALTHCARE SERVICES GROUP, INC.
                          CONDENSED CONSOLIDATED
                           STATEMENTS OF INCOME
                                (Unaudited)


                                                 For the Nine Months Ended
                                                       September 30,
                                                    2010          2009
                                                ------------- -------------
Revenues                                        $ 571,868,000 $ 510,134,000
Operating costs and expenses:
   Cost of services provided                      492,196,000   438,950,000
   Selling, general and administrative             41,539,000    36,328,000
                                                ------------- -------------
Income from operations                             38,133,000    34,856,000
Other income:
    Investment and interest income                  1,549,000     3,803,000
                                                ------------- -------------
Income before income taxes                         39,682,000    38,659,000
Income taxes                                       14,364,000    14,883,000
                                                ------------- -------------
Net income                                      $  25,318,000 $  23,776,000
                                                ============= =============

Basic earnings per common share                 $         .58 $         .55
                                                ============= =============

Diluted earnings per common share               $         .57 $         .54
                                                ============= =============

Cash dividends per common share                 $         .66 $         .54
                                                ============= =============
Basic weighted average number of common shares
 outstanding                                       43,964,000    43,540,000
                                                ============= =============

Diluted weighted average number of common
 shares outstanding                                44,677,000    44,224,000
                                                ============= =============




                      HEALTHCARE SERVICES GROUP, INC.
                  CONDENSED CONSOLIDATED BALANCE SHEETS
                                (Unaudited)


                                                September 30, December 31,
                                                    2010          2009
                                                ------------- -------------
Cash and cash equivalents                       $  26,109,000 $  31,301,000
Marketable securities, net                         44,498,000    52,648,000
Accounts receivable, net                          108,363,000   104,356,000
Other current assets                               24,350,000    23,865,000
                                                ------------- -------------
  Total current assets                            203,320,000   212,170,000

Property and equipment, net                         5,591,000     4,391,000
Notes receivable- long term, net                    6,084,000     4,623,000
Goodwill, net                                      16,955,000    17,087,000
Other Intangible Assets, net                        7,730,000     8,862,000
Deferred compensation funding                      12,510,000    10,783,000
Other assets                                       10,082,000     7,976,000
                                                ------------- -------------

Total Assets                                    $ 262,272,000 $ 265,892,000
                                                ============= =============


Accrued insurance claims- current               $   6,032,000 $   4,844,000
Other current liabilities                          18,186,000    29,873,000
                                                ------------- -------------
  Total current liabilities                        24,218,000    34,717,000

Accrued insurance claims- long term                14,074,000    11,302,000
Deferred compensation liability                    12,837,000    11,099,000
Stockholders' equity                              211,143,000   208,774,000
                                                ------------- -------------

Total Liabilities and Stockholders' Equity      $ 262,272,000 $ 265,892,000
                                                ============= =============

OAKLAND, CA–(Marketwire – October 12, 2010) –  It took vision, years of planning and advocacy; a true labor of love. On Thursday, October 7 Alameda’s newest partner for family members dealing with their own very personal journeys — The Family Education and Resource Center (FERC) (www.askferc.org) — celebrated one year of “being there” for residents of Alameda County. More importantly, the event, called “Partners In This Journey,” celebrated those who worked tirelessly for years setting the stage for this program to finally be funded with Mental health Services Act funds. The event took place at Oakland’s Waterfront Hotel and coincided with National Mental Illness Awareness Week (October 3 – 9, 2010).

“We wanted to thank everyone who participated in the visioning, creation and existence of FERC (www.askferc.org).”

“We’ve been there; we can help,” says Karina Foote, FERC Program Director, noting that every member of the FERC staff have the lived experience of supporting a loved one with mental illness.

As one in four Americans either suffer with a mental illness themselves or has a family member so dealing, the services provided by FERC are crucial. Plus, in challenging economic times, the strain on individuals and families is even greater. To help meet that need — and meet the need in ways that are most comfortable to their clients — FERC provides both in person and telephone support. All services are free. 

“We call it our ‘warm line’ telephone service,” says Foote. “There is still so much misunderstanding, fear and therefore much stigma around issues of mental health and illness; it is sometimes easier for our clients to discuss their needs over the phone.” Also, cultural competency is a vital part of our mission. “We meet our clients where they are in terms of their ability to cope with their own and the struggles of their loved ones,” says Annie Kim, Lead Family Advocate.

Staff at FERC help individuals navigate the often complex web of behavioral health services. When needed, FERC staff will even make the initial contact or appointment with an agency on behalf of an individual. In addition, FERC staff assist with locating resources such as mental health care, housing, day programs, and recreation, and offer guidance about managing family relationships and developing coping strategies. “We direct people to available and appropriate services,” says Kim. People who contact FERC in the midst of a crisis may be directed to the appropriate crisis management services.

As a new program of the Mental Health Association of Alameda County (contracted for service with ACBHCS), FERC has been reaching out to clients and organizations to offer their services. Staff members are available not only on site, but also to facilitate or take part in support groups for other organizations. As FERC continues to grow, staff also plans to develop support groups for transition age youth (15-27) who have a family member with a mental illness and to provide education about mental illness for classroom teachers.

FERC’s main office is in Oakland’s Eastmont Town Center (7200 Bancroft Avenue, Suite 269), with additional offices in Fremont and Hayward. A site in Livermore will open later this fall. Office hours are Monday through Friday, 9am-5pm and people from anywhere in Alameda County are welcome to drop in with questions or to conduct research in the library or on the Internet.

“For many years, we envisioned a safe harbor for people in Alameda seeking mental health services,” said Margot Dashiell, Chairperson of the Alameda County Family Coalition, speaking at the October 7^th event. “FERC has become that safe harbor.”

The Family Education and Resource Center (FERC) is a new and innovative family/caregiver-centered program that will provide information, education and support services to family/caregivers of children, adolescents, transitional age youth, adults or older adults with serious emotional disturbance or mental illness living in all regions of Alameda County. These services will be provided in a culturally competent manner, reaching out to people of all ethnicities. For more information about FERC, call 510-746-1700. To access services, families can call 1-888-896-FERC (3372).

Click here to see all recent news from this company

NEW ROCHELLE, NY–(Marketwire – October 12, 2010) –  Somnia Anesthesia, the premier anesthesiology practice management company, today announced the appointment of John Ansorge to the position of chief financial officer. In this newly created role, Ansorge will assume oversight of the company’s financial operations, with responsibility for accounting, financial planning and reporting, budgets and forecasting. He will report to Somnia President and CEO, Marc E. Koch, MD, MBA.

Mr. Ansorge joins Somnia with more than 20 years’ experience in hospital finance. Most recently, he held the position of interim CFO for Stamford Health System in Stamford, Connecticut, a 305-bed teaching hospital affiliated with the Columbia University Medical School and posting net revenues of $450M. While there, he reorganized the Patient Access Department, initiated and controlled a cost savings plan aimed at reducing expenses, reduced supply costs, and successfully reorganized the hospital’s debt during unfavorable market conditions.

“John is a highly talented healthcare finance professional who rounds out our world-class executive team,” said Dr. Koch. “He brings tremendous business acumen to the organization and we’re confident he will put in place the financial structure needed to support our continued growth in the hospital market.”

Prior to joining Stamford Health System, Mr. Ansorge held the post of chief financial officer at a variety of hospitals including Lincoln Park Hospital and Ephraim McDowell Regional Medical Center, located in Chicago and Kentucky, respectively. While at Lincoln, he reduced cash flow losses and increased collections. He also moved the hospital’s EBITA results into positive territory for the first time in five years.

Earlier in his career, Mr. Ansorge honed his healthcare accounting and finance skills in a series of roles requiring increasing levels of responsibilities at Humana, Inc. and Columbia/HCA Healthcare Corporation.

Mr. Ansorge holds a BS, Healthcare Management, from the University of Alabama.

About Somnia
Somnia Inc., founded in 1996, is the most experienced physician-owned and operated clinical anesthesia management company servicing healthcare facilities nationwide. Somnia specializes exclusively in building and comprehensively managing world-class anesthesia teams that consistently deliver the highest quality of patient care. The company expertly manages all areas of anesthesia including leadership, recruiting, revenue cycle management, payor contracting and quality assurance with the largest in-house management infrastructure in the United States.

For more information visit: www.somniainc.com. Follow us on Twitter: http://www.twitter.com/somniainc.
Add us on LinkedIn: http://www.linkedin.com/in/somniaanesthesia.

Click here to see all recent news from this company

DALLAS, TX–(Marketwire – October 12, 2010) –  For the entire month of October, Pizza Patron will be raising funds in all its stores for the St. Jude Children’s Research Hospital.

Pizza Patron stores have St. Jude posters and counter top displays up that explain why and how to donate. St. Jude is a pediatric treatment and research facility in Memphis, Tennessee which treats children with cancer and other catastrophic diseases. Founded by entertainer Danny Thomas on the premise that “no child should die in the dawn of life,” the hospital is well-known for being the only pediatric cancer center in the country that won’t charge parents for any treatment not covered by their insurance plan. No child is ever turned away from St. Jude’s because of his or her family’s inability to pay.

“We were really amazed by the professionalism and support shown by St. Jude’s team. They visited every Pizza Patrón across the country personally, and provided training to our team members,” said Andrew Gamm, brand director for Pizza Patrón. “The response from our employees has been overwhelmingly positive; everyone is very excited to play a part in helping this amazing charity.”

Gamm explained that donations of any size can be given and the donation will be indicated on the receipt in a separate line item. One-hundred percent of the money raised will go to St. Jude’s. 

In 2010, St. Jude Children’s Research Hospital was named the number one children’s cancer hospital in the United States by U.S. News & World Report. Discoveries at St. Jude have changed how doctors treat children with cancer and other catastrophic illnesses. Since St. Jude was established, the survival rate for acute lymphoblastic leukemia, the most common type of childhood cancer, has increased from 4 percent in 1962 to 94 percent today. St. Jude has treated children from across the U.S. and from more than 70 countries. Doctors around the globe consult with St. Jude on their toughest cases. Additionally, St. Jude has an International Outreach Program to improve the survival rates of children with catastrophic illnesses worldwide through the transfer of knowledge, technology and organizational skills.

About Pizza Patrón
Pizza Patrón, America’s #1 Latin pizza brand, offers traditional pizza, wings and sides in its community based, Latin-influenced stores. Pizza Patrón was founded by restaurateur Antonio Swad in 1986, in Dallas, Texas, and today operates 100 dine-in and carry-out restaurants in seven states with 40 more under development. Pizza Patrón has franchise opportunities available in prime markets throughout the country offering a proven system for hard-working franchisee candidates. In 2007, the brand received international news coverage when it decided to accept Mexican Pesos at all of its locations, gaining over 500,000,000 media impressions worth over $30 million in the U.S. alone. The company’s medium AMIGO PIZZAS® start as low as $4 and X-Large LISTA-NOW READY™ pepperoni pizzas start as low as $6 all day, every day.

Website – www.pizzapatron.com
Facebook – http://www.facebook.com/pizzapatron
Twitter – http://www.twitter.com/pizzapatron
MySpace – http://www.myspace.com/mypizzapatron
YouTube – http://www.youtube.com/user/pizzapatroncorp

Click here to see all recent news from this company

IRVINE, CA–(Marketwire – October 12, 2010) –  SK&A, A Cegedim Company, today announced results of its ongoing survey of U.S. medical offices to determine the policies for allowing pharmaceutical and other medical industry sales-rep access to physicians and other prescribers. The Physician Access survey is based on completed telephone interviews with more than 237,000 medical sites representing 680,000 physicians.

While other similar studies and services are based on sample surveys, projections and manufacturer-based data, SK&A has invested in a comprehensive, ongoing survey to directly profile every U.S. medical office and record their exact policies for contact with sales reps. SK&A surveys its Office-Based Physician database every six months from its Research Center in Irvine, California.

After three years of measuring access to physicians, what has emerged is a portrait of doctors and their willingness to interact with sales representatives. Nearly half of the physicians surveyed say they require or prefer appointments to be made by reps prior to one-on-one meetings, while about 23 percent of doctors refuse to see sales reps at any time at any of their practice locations.

According to the survey, the percentage of doctors who will not allow access unless an appointment is scheduled increases measurably when their practices are owned by hospitals or health systems. In many cases, the appointment must be made through a headquarters location rather than the practice site itself.

“As prescribers become busier and less accessible, understanding physician access preferences is critical to successful sales and marketing resource planning, and execution,” said SK&A’s Dave Escalante, Vice President of Data and Information Solutions. “The information available from SK&A’s up-to-date profiling of physician access gives sales and marketing organizations deeper insight, enabling them to target more efficiently while not jeopardizing important relationships.”

Managing sales-rep calls is a significant part of the physician work week. According to the latest findings of the Physician Access study, most doctors (98 percent) report their offices are visited by up to 20 industry reps per week or one rep an average of every two hours.

Other significant trends found within the survey include:

• Specialty physicians are less likely to grant sales reps access than general practitioners. The top-three most accessible physician areas are allergists/immunologists (4.2% no-see rate), orthopedic specialists (5.1%) and diabetes specialists (7.6%). The least accessible physicians are diagnostic radiologists (92.1% no-see rate), pathologists (91.8%) and neuroradiologists (90.6%).The access rates for these specialists have remained constant for the last two bi-yearly reporting periods.

• Offices with fewer patients seen daily are less likely to see sales reps. Sites with a daily patient volume of one to 10 have a no-access rate of 28.9 percent, while those with a daily patient volume of 31 to 40 have a 13.4 percent no-access rate. Sites that are less busy are often staffed by one physician who is not able to take a break from patient appointments to visit with industry sales reps.

• Health system- and hospital-owned offices are less likely to grant sales reps access. Health system- and hospital-owned offices have no-access rates of 30.8 percent and 29.6 percent, respectively. Non-health system and hospital-owned offices have no-access rates of 21.4 percent and 21.7 percent, respectively.

• Larger practices are less likely to grant sales reps access. Offices with one to two physicians have a no-access rate of 13.3 percent while offices with 10 or more physicians have a no-access rate of 42.2 percent.

• Physician offices in the Western U.S. are least likely to allow sales reps access. The South had the lowest no-access rate of 19.4 percent, and the West had a 28.4 percent no-access rate.

The Physician Access report is available to help healthcare marketers and sales executives in appointment-setting and connecting personally with physicians. SK&A has compiled access data at the physician level and offers custom databases selectable by geography, specialty, office size, patient volume, practice ownership and other variables upon request. 

Editor’s Note: For a copy of the summary findings for publication, please contact Jack Schember, SK&A Director of Marketing, at 800-752-5478, ext. 1259. 
 
About SK&A, A Cegedim Company:
SK&A is a leading provider of healthcare information solutions and research. SK&A, as part of Cegedim’s global OneKey® offering, researches and maintains contact and profiling information for over two million healthcare practitioners, including 800,000-plus prescribers. SK&A also offers the only 100-percent telephone-verified database of email addresses of U.S. prescribers and professionals working at active healthcare sites. SK&A’s customers include many of America’s most recognized healthcare, life sciences and pharmaceutical companies. Please visit www.skainfo.com for more information or www.skalivecounts.com for counts and ordering. 

About Cegedim:
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,600 people in more than 80 countries and generated revenue of EUR 874 million in 2009. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com

Click here to see all recent news from this company

NEW YORK, NY–(Marketwire – October 12, 2010) –  Healthnostics, Inc., (PINKSHEETS: HNSS), a medical manufacturing and biotechnology analytics company, has purchased a major manufacturer of specialty medical products. There will be an immediate positive impact on revenue and earnings commencing in the 1^st Quarter of 2011. Details will be forthcoming in subsequent press releases.

“This accretive purchase directly ties into the Company’s recent acquisition of World Wide Wipes Co., and it will result in even more substantial impact on our profitability and earnings per share,” said Alan Grofe, president.

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics’ major products include: Worldwide Wipes Co., a manufacturer and distributor of medical and other wipes, MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com. And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

SAN DIEGO, CA–(Marketwire – October 12, 2010) –  MIR3, the innovator of real-time Intelligent Notification™ and response technology, today announced that Concerro, provider of SaaS-based workforce management and emergency response systems that facilitate real-time information access, has chosen inEnterprise™ software to integrate with their software offerings and to resell as a stand-alone product.

Concerro has been using inEnterprise to add Intelligent Notification to their flexible workforce management system, ShiftSelect™, for more than two years. They have not only renewed their contract, but extended it to include development within their CommandAware™ emergency response and incident management system and have also agreed to act as resellers of the stand-alone inEnterprise platform. Now Concerro is able to offer their customers both a command console with integrated notification and a separate platform that can be used for important message delivery and mass notification.

“With MIR3, we can offer our customers real-time notification that helps communicate important messages among hospital staff wherever they are, no matter what communication device they use,” said Michael Meisel, VP of product management and marketing for Concerro. “Any number of users can be alerted of an urgent staffing need or emergency situation quickly and simultaneously, which saves time and improves communication when it’s needed the most.”

“The partnership between MIR3 and Concerro supports our strategy of penetrating the healthcare and hospital industries and provides solid benefits to both partners,” said Rene Grossrieder, VP, worldwide channels and alliances for MIR3. “Expanding on our partnership, both from a development and reseller standpoint, provides hospitals with the most comprehensive solution on the market. These new solutions will help them to take action more quickly, streamline costs and enhance compliance.”

ShiftSelect is a workforce management system used to improve shift visibility and align organization and workforce needs in a hospital setting. CommandAware is an emergency response and incident management system for hospitals that helps these institutions become HICS IB and NIMS compliant as well as meet Joint Commission preparedness standards.

inEnterprise uses Intelligent Notification technology to decrease time spent on manual and often unreliable means of contacting staff, vendors and partners, allowing users to deliver important messages to hundreds or thousands of people at once, no matter where they are and by a wide variety of communication means. Intelligent Notification technology will provide Concerro customers with an automated way to increase and improve communications, augmenting their workforce management and disaster response systems. 

ABOUT MIR3

MIR3, Inc. is the leading developer of Intelligent Notification and response software, which helps organizations enhance communication abilities, protect assets, and increase operational efficiency. MIR3 technology enables advanced rapid, two-way mass communication for IT, business continuity, and enterprise operations for more than 85 of the FORTUNE 100 companies, as well as government entities, universities, and companies of all sizes in more than 130 countries. For more information, visit www.mir3.com.

ABOUT CONCERRO

Concerro is a healthcare Software-as-a-Service (SaaS) company that provides healthcare workforce and emergency response and incident management systems that improve both quality of life and your bottom line by reducing costs through optimization rather than reduction. The company has won numerous awards and recognition, including being named to the prestigious Inc. 5000 for three consecutive years, and receiving Red Herring’s 100 most promising private technology ventures in North America and Best of SaaS Showplace (BoSS) awards. To learn more, visit www.concerro.com, or follow Concerro on Twitter.

BOCA RATON, FL–(Marketwire – October 12, 2010) –  David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that the Company completed the sale of $2.75 million principal amount, 10% convertible notes due in 2012 and warrants to purchase an aggregate of 6,111,000 shares of Vicor’s common stock on October 8, 2010. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i^® nonlinear algorithm and software. Vicor is currently in the process of commercializing diagnostics that accurately risk stratify specific target populations for future pathological events, including congestive heart failure patients for cardiac death resulting from arrhythmia or pump failure, diabetics for diabetic autonomic neuropathy (DAN), and trauma victims for imminent death absent immediate lifesaving intervention.

“We’re extremely pleased to have secured this financing, especially given the current state of the economy. We are gratified by our investors’ confidence in the market potential of our non-invasive risk stratification products, which we are beginning to realize. This financing will provide us with the working capital needed to continue to execute our business plan,” stated Mr. Fater.

About Vicor Technologies, Inc.
Vicor Technologies is a biotechnology company creating innovative non-invasive diagnostics employing its patented, proprietary point correlation dimension algorithm (PD2i^®). The PD2i^® nonlinear algorithm is a deterministic, nonlinear measure of electrophysiological potentials that predicts future pathological events with a high degree of accuracy in target populations.

Vicor currently has three products employing the PD2i^® nonlinear algorithm. The PD2i Analyzer™, which has FDA 510(k) marketing clearance, measures heart rate variability; physicians performing diagnostic tests with the PD2i Analyzer™ are able to receive reimbursement under existing CPT codes. The PD2i VS™ (Vital Sign), in clinical trials under a collaborative effort with the U.S. Army Institute for Surgical Research (http://www.usaisr.amedd.army.mil/), risk stratifies combat and civilian trauma victims. The PD2i CA™ (Cardiac Analyzer), in multiple clinical trials, identifies patients at risk of sudden cardiac death.

Vicor anticipates additional applications employing the PD2i^® nonlinear algorithm to enable early detection and risk stratification for a variety of other disorders and diseases. Additional information is available at www.vicortech.com.

Disclaimer
The appearance in this release of name-brand institutions, such as the U.S. Army Institute for Surgical Research, does not constitute endorsement by these institutions of the information, products, or services contained therein.

Caution Regarding Forward-Looking Statements
Forward-looking statements in this press release are based on current plans and expectations that are subject to uncertainties and risks, which could cause our future results to differ materially. The following factors, among others, could cause our actual results to differ: our ability to successfully complete the normal range study for PD2i^®values; our ability to generate revenues from the sale of the PD2i Analyzer™; our ability to obtain FDA approval of our 510(k) submission to secure a claim for the PD2i CA™(Cardiac Analyzer) for risk stratifying congestive heart failure patients at elevated risk of cardiac mortality and our ability to obtain marketing clearance from the FDA for the PD2i VS™ (Vital Sign) for military and civilian applications; our ability to develop additional applications for the PD2i^®algorithm; our ability to continue to receive financing sufficient to continue operations and complete critical clinical trials; our ability to continue as a going concern; our ability to successfully develop products based on our technologies; our ability to obtain and maintain adequate levels of third-party reimbursement for our products; the impact of competitive products and pricing; our ability to receive regulatory approval for our products; the ability of third-party contract research organizations to perform preclinical testing and clinical trials for our technologies; the ability of third-party manufacturers to manufacture our products; our ability to retain the services of our key personnel; our ability to market and sell our products successfully; our ability to protect our intellectual property; product liability; changes in federal income tax laws and regulations; general market conditions in the medical device and pharmaceutical industries; and other matters that are described in Vicor’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and subsequent filings with the Securities and Exchange Commission. Forward-looking statements in this press release speak only as of the date of the press release, and we assume no obligation to update forward-looking statements or the reasons why actual results could differ.

Release 10-19

Click here to see all recent news from this company

MADISON, WI–(Marketwire – October 12, 2010) – TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, saw attendance double over 2009 levels for its annual Asia Pacific User Education Symposium, held October 2-3, 2010, in Incheon, South Korea. More than 190 TomoTherapy^® treatment system users from across the Asia Pacific region convened to share insights on a growing body of clinical evidence of the efficacy of TomoTherapy radiation treatments. The increased attendance underscores the rapid adoption of the solution in the region, where the installed base of TomoTherapy systems has increased by 27 percent in just the last year.

“The Asia Pacific User Education Symposium was extremely valuable for all TomoTherapy users in the region,” said Dr. Yong Chan Ahn, associate professor and chairman of Radiation Oncology at Samsung Medical Center in South Korea, who also served as chairman of the event. “We had the opportunity to see a great deal of excellent clinical research, with many presentations focused on those diseases, such as liver cancer, that are difficult to treat and commonly seen in Asia. I look forward to the maturing of the results we are seeing, further showing the benefits of TomoTherapy in these areas.”

The Asia Pacific region is one of the fastest growing markets for TomoTherapy, with its installed base experiencing consistent growth of about 30 percent annually for the last few years. The key growth drivers for the region have been Korea, Japan and, more recently, China. Also, in the past year, expansion into Malaysia and Australia have added to the growth. Japan remains the largest market in the Asia Pacific region with 19 TomoTherapy systems installed, second overall only to the United States. South Korea is the second largest market in the region, with 14 systems currently installed.

“We were extremely pleased to see the representation of our customers at this meeting. Their presence overwhelmingly confirms that TomoTherapy offers very high quality treatment and is considered the gold standard in radiation therapy,” said H.W. Jang, CEO of Oncology Total Solutions, a distributor of TomoTherapy technology in South Korea and host of the symposium. “We are proud to have a very strong relationship with TomoTherapy to provide the best quality service, which strengthens our bond with our customers and helps them in the delivery of treatment to their patients.”

The User Education Symposium featured a strong scientific program covering topics from treatment of liver and nasopharynx cancers, to sparing of the hippocampus during treatment for brain cancer. Of particular note were two presentations:

• Dr. Chul Seung Kay of Incheon St. Mary Hospital of Korea presented on five years of clinical experience with TomoTherapy technology at his institution, citing multiple areas of investigation. In the treatment of advanced hepatocellular cancer with TomoTherapy, results showed a median survival rate double that of similar patients treated by other means. Other disease studies showed positive response to TomoTherapy treatments, particularly patients with pulmonary metastases who did not respond to multiple cycles of systemic chemotherapy. Researchers also reported on the feasibility of TomoTherapy to treat inoperable, advanced pancreatic cancers, and discussed ongoing studies on extracranial metastases, re-irradiation of recurrent rectal, head and neck cancers and oligometastases from breast cancer.

• Dr. Chikao Sugie of Nagoya City University, Japan detailed his center’s experience with craniospinal treatments on a group of 12 patients, median 14 years of age. For treatment of various brain tumors, TomoTherapy plans were superior to conventional linear accelerator-based plans with regard to the homogeneity and conformality in planning target volume.

“We have treated more than 1,300 patients with a broad spectrum of disease with TomoTherapy since September 2006,” said Dr. Pei-Wei Shueng, chief of Radiation Oncology at Far Eastern Hospital in Taiwan. “We have found that helical TomoTherapy provides us with a flexible treatment fractionation scheme that offers better dose coverage and highly conformal dose distributions, combined with an impressive ability to simultaneously spare multiple critical structures.”

“The degree of clinical interest in TomoTherapy in the Asia Pacific region is very impressive, as evidenced in the participation in our symposium. In just its third year, the Asia Pacific User Education Symposium has grown to be the largest one TomoTherapy hosted this year,” said Fred Robertson, M.D., TomoTherapy’s CEO. “Based on the response to our symposium and the clinical evidence coming out of the region, we believe that the stage is set for continued significant adoption of the TomoTherapy platform throughout the Asia Pacific region.”

The Asia Pacific event is the final in a series of three User Education Symposia held in 2010. The first, for the Americas region, took place in April in San Diego, Calif., and the second, for Europe and the Middle East, was held in May in Marbella, Spain. 

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy^® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art^® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD^™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

Forward-Looking Statements
Statements in this release regarding future products or product capabilities, events, expectations and other similar matters, including but not limited to statements using the terms “may,” “should,” “suggests” or “indicates” constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including but not limited to factors such as our ability to integrate acquired assets, ability to protect intellectual property, risks of interruption due to events beyond the company’s control, and the other risks listed from time to time in TomoTherapy’s filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. These forward-looking statements represent TomoTherapy’s judgments as of the date of this press release. TomoTherapy assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events or otherwise.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries

TARPON SPRINGS, FL–(Marketwire – October 11, 2010) – Pinnacle Home Care of Pinellas today announced that it has been named one of the top 500 home health agencies in the country, according to the 2010 HomeCare Elite™. Now in its fifth year, the HomeCare Elite identifies the top 25 percent of home health agencies in the United States and further highlights the top 100 and top 500 agencies overall. Winners are ranked by an analysis of performance measures in quality outcomes, quality improvement, and financial performance.

“The 2010 HomeCare Elite winners continue to demonstrate a commitment to providing their patients with the best possible care while performing at the highest level,” said Amanda Twiss, CEO of OCS HomeCare. “We congratulate Pinnacle Home Care of Pinellas on being one of the top home care agencies in the country. In addition, we salute all forward-thinking providers who are already working on measuring and improving their performance using OASIS-C outcomes and process measures and HH-CAHPS results. This important data will also be used in identifying the HomeCare Elite in the future.”

Pinnacle Home Care’s co-owner, Margo McElveen, RN, credits “staff commitment to exceeding both patient and physician expectations as well as the staff’s compassion when delivering quality of care” with the company’s ability to rank as one of the HomeCare Elite. “Our staff’s dedication to individualized patient care and their successful outcome is what sets us apart,” she said.

 “On the fifth anniversary of HomeCare Elite, DecisionHealth would like to congratulate all of the winners who have achieved excellent clinical and financial outcomes, especially during times of such drastic regulatory changes,” added Marci Heydt, executive editor of DecisionHealth’s Home Health Line.

The 2010 HomeCare Elite is the only performance recognition of its kind in the home health industry. The 2010 HomeCare Elite is brought to the industry by OCS HomeCare, the leading provider of homecare information, and DecisionHealth, publisher of home care’s most respected independent newsletter Home Health Line. The data used for this analysis were compiled from publicly available information. The entire list of the 2010 HomeCare Elite agencies can be viewed by visiting the OCS HomeCare website at www.ocshomecare.com.

MUNDELEIN, IL–(Marketwire – October 11, 2010) –  The more than 4,000 healthcare workers and breast cancer survivors who danced in the Pink Glove Dance: The Sequel video are still working to raise awareness for breast cancer prevention — and maybe inspire more people to dance and support the cause. Medline Industries, Inc. — the makers of the pink gloves and creator of the dance videos — has just posted videos from each of the 12 healthcare facilities and breast cancer survivor groups that participated in the Pink Glove Dance sequel. The videos can be viewed at www.pinkglovedance.com.

“Our video involved doctors and nurses, employees, students, survivors and others from the IU Simon Cancer Center, the IU school of nursing and medicine, and Clarian Health,” said Michael Schug, communications specialist at the Indiana University Melvin and Bren Simon Cancer Center. “So, a lot of our people danced to help spread the word about breast cancer awareness. To let our dancers and community know about our custom video, we have done mass e-mailings, posted it on our Facebook pages, YouTube channels, and Flickr accounts. It’s definitely gone viral around here.” 

Linda Rumore, purchasing agent for Thibodaux Regional Medical Center in Thibodaux, Louisiana, and the coordinator of the shoot at the hospital said: “The video is such a morale booster for all of us throughout the hospital because it’s such a great cause. It’s like Christmas Eve here because everyone is so excited and honored to be involved in the video.”

The original Pink Glove Dance video was launched about a year ago with healthcare workers at Providence St. Vincent Medical Center in Portland, Oregon. Because of the overwhelming response from the video (now with more than 11.8 million views on YouTube), Medline went across the country and into Canada to film healthcare workers and breast cancer survivors dancing in pink gloves to raise awareness for breast cancer prevention. The result was The Pink Glove Dance: The Sequel, which was launched September 17, featuring workers from 11 hospitals, three nursing homes and breast cancer survivors in five different locations from the Golden Gate Bridge to New York’s Times Square and several points in between. (See list of participating facilities and locations at the end of this release.)

“I cannot begin to tell you what participating in the video does for someone like me — a survivor. After going through hell and back and being able to have fun, dance and share these moments, it’s amazing and it shows how Medline really cares and thinks about the people they are serving,” said Annette Rodriguez, a New York City resident and participant in the survivor shoot in Times Square. “Being in the video shows that we aren’t just pieces of meat being dealt with, we are people too. People aren’t noticing the lack of hair or how skinny or fat someone is getting from treatments. It made all of us feel beautiful and allowed us to just have fun, let loose.” 

Since the original video was released last November, the Pink Glove Dance has grown way beyond Medline’s efforts. In the past year, more than 80 pink glove videos have been posted on YouTube from around the world (including Germany, The Netherlands and Canada) featuring people dancing in pink gloves to support breast cancer awareness. Some of the more interesting videos feature the Penn State women’s basketball team, students in elementary schools, high school cheerleaders, grandmothers, and even cats and babies wearing pink gloves.

Medline originally developed the pink exam gloves and the Pink Glove Dance video as a way to spread awareness for breast cancer prevention.

“Breast cancer awareness and prevention is now the largest philanthropic cause in our company,” said Andy Mills, president of Medline. “The pink gloves are symbolic of healthcare workers’ connection with breast cancer patients. Prevention and early detection are among the most important ways you can fight breast cancer and that is why our campaign focuses on helping fund mammograms for women who cannot afford them.”

Medline donates $1 to the National Breast Cancer Foundation for every case sold of its pink gloves to help fund mammograms for underserved women. Medline has donated more than a half million dollars to provide education and free mammograms to those in need and continues to make contributions every year.

About Medline
As the nation’s largest privately held manufacturer and distributor of medical supplies, Medline is focused on helping to improve the quality of care for patients and residents. Breast cancer awareness is a natural extension of Medline’s corporate mission to help save lives through the early detection of breast cancer. (Visit www.medline.com/breast-cancer-awareness for details). Based in Mundelein, Ill., Medline manufactures and distributes more than 100,000 products to hospitals, extended care facilities, surgery centers, home care dealers and agencies, and other markets.

Who is in the sequel?
The sequel features more than 4000 healthcare workers and breast cancer survivors from 14 separate facilities in the U.S. and Canada (11 hospitals, 3 nursing homes and 5 separate breast cancer survivor shoots). Here is a list of participating locations:

Providence St. Vincent Medical Center
Portland, Oregon

University of Minnesota Medical Center, Fairview
Minneapolis, Minnesota

Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana

Tallahassee Memorial Healthcare, Inc.
Tallahassee, Florida

Saint Michael’s Medical Center
Newark, New Jersey

The Medical Center of Plano
Plano, Texas

HCA Johnston?Willis Hospital
Richmond, Virginia

Scripps Memorial Hospital La Jolla
La Jolla, California

Sky Ridge Medical Center
Lone Tree, Colorado

Thibodaux Regional Medical Center
Thibodaux, Louisiana

Capital Health
Halifax, Nova Scotia

Burgess Square Healthcare and Rehab Centre
Westmont, Illinois

Isabella Geriatric Center
New York, New York

Lorien Health Systems
Maryland

Breast Cancer Survivor Sites
New York City
Chicago
San Francisco
Minneapolis
Portland